chemQ bioscience LLC is a privately owned research and development company focusing on manufacturing of in vitro diagnostic products. The company is located in Research Triangle Park, home to more than 170 global companies and three major and prestigious universities, Duke University, University of North Carolina (Chapel Hill) and North Carolina State University. The founder, members and scientific advisory board of the company have many years of experience in medicinal chemistry, clinical oncology, clinical pathology and molecular biology.
Cancer remains the leading cause of death worldwide. It is estimated that more than 7.5 million people lose their fight against cancer each year. The disease once associated with rich and developed societies, is now taking its highest toll on middle- and poor-income societies. About 70% of cancer deaths (5.5 million people) now occur in developing countries.
The good news is that thousands of people beat cancer each year if caught in the early stages. Early diagnosis of cancer not only increases the chances for successful treatment, but also the treatment is often simpler and less costly. Therefore, we believe it is essential to educate and advocate early diagnosis, provide cost effective screening methods and affordable screening products to prevent the development of cancer or to diagnose it in the early stages.
We thank our clients and people who believe in our mission and encourage us to continue our efforts in developing new cost effective screening products for cancer diagnostics.